A detailed history of Fmr LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,490,204 shares of TMDX stock, worth $680 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,490,204
Previous 4,838,880 7.21%
Holding current value
$680 Million
Previous $358 Million 89.03%
% of portfolio
0.04%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$72.62 - $150.62 $25.3 Million - $52.5 Million
-348,676 Reduced 7.21%
4,490,204 $676 Million
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $718,236 - $911,530
10,136 Added 0.21%
4,838,880 $358 Million
Q4 2023

Feb 13, 2024

BUY
$36.74 - $81.08 $4.18 Million - $9.23 Million
113,874 Added 2.42%
4,828,744 $381 Million
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $75.2 Million - $135 Million
1,407,171 Added 42.54%
4,714,870 $258 Million
Q2 2023

Aug 11, 2023

BUY
$66.23 - $88.73 $3.41 Million - $4.56 Million
51,428 Added 1.58%
3,307,699 $278 Million
Q1 2023

May 11, 2023

SELL
$53.63 - $82.33 $1.09 Million - $1.68 Million
-20,411 Reduced 0.62%
3,256,271 $247 Million
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $25.9 Million - $42.7 Million
-663,474 Reduced 16.84%
3,276,682 $202 Million
Q3 2022

Nov 10, 2022

SELL
$31.56 - $55.75 $8.11 Million - $14.3 Million
-256,961 Reduced 6.12%
3,940,156 $164 Million
Q2 2022

Aug 12, 2022

BUY
$20.56 - $32.15 $40,071 - $62,660
1,949 Added 0.05%
4,197,117 $132 Million
Q1 2022

May 13, 2022

BUY
$12.58 - $26.94 $376,418 - $806,098
29,922 Added 0.72%
4,195,168 $113 Million
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $262,281 - $447,356
13,689 Added 0.33%
4,165,246 $79.8 Million
Q3 2021

Nov 15, 2021

BUY
$25.92 - $34.51 $206,686 - $275,182
7,974 Added 0.19%
4,151,557 $137 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $89.6 Million - $166 Million
4,143,583 New
4,143,583 $137 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $4.82B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.